X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
hematology (31) 31
index medicus (29) 29
oncology (29) 29
myelodysplastic syndromes (28) 28
aged (27) 27
prognosis (26) 26
female (24) 24
male (24) 24
middle aged (22) 22
adult (19) 19
aged, 80 and over (18) 18
mds (16) 16
medicine & public health (16) 16
medicine/public health, general (15) 15
myelodysplastic syndromes - genetics (15) 15
acute myeloid-leukemia (14) 14
cancer (14) 14
leukemia (14) 14
scoring system (13) 13
myelodysplastic syndromes - mortality (12) 12
classification (11) 11
azacitidine (10) 10
myelodysplastic syndromes - diagnosis (10) 10
analysis (9) 9
prognostic scoring system (9) 9
stem cells (9) 9
survival (9) 9
azacitidine - therapeutic use (8) 8
comorbidity (8) 8
hematology, oncology and palliative medicine (8) 8
myelodysplastic syndromes - classification (8) 8
research (8) 8
chemotherapy (7) 7
chromosome aberrations (7) 7
internal medicine (7) 7
medicine, general & internal (7) 7
myelodysplastic syndromes - pathology (7) 7
oncology, experimental (7) 7
risk factors (7) 7
treatment outcome (7) 7
world-health-organization (7) 7
adolescent (6) 6
antimetabolites, antineoplastic - therapeutic use (6) 6
care and treatment (6) 6
chronic myelomonocytic leukemia (6) 6
conventional care regimens (6) 6
cytogenetic analysis (6) 6
endocrinology (6) 6
gastroenterology (6) 6
medical colleges (6) 6
myelodysplastic syndromes - therapy (6) 6
pneumology/respiratory system (6) 6
proposals (6) 6
retrospective studies (6) 6
survival analysis (6) 6
survival rate (6) 6
transplantation (6) 6
aml (5) 5
austria (5) 5
austrian azacitidine registry (5) 5
cmml (5) 5
cytogenetics (5) 5
diagnosis (5) 5
hemic and lymphatic diseases (5) 5
impact (5) 5
karyotype (5) 5
response criteria (5) 5
risk assessment (5) 5
targeted therapy (5) 5
young adult (5) 5
animals (4) 4
austria - epidemiology (4) 4
bone marrow - pathology (4) 4
cancer research (4) 4
clinical medicine (4) 4
disease progression (4) 4
hypomethylating agents (4) 4
international working group (4) 4
leukemia, myeloid, acute - genetics (4) 4
medical research (4) 4
prognostic factors (4) 4
prognostic-factors (4) 4
stem-cell transplantation (4) 4
syndromes mds (4) 4
time factors (4) 4
world health organization (4) 4
acute disease (3) 3
acute-leukemia (3) 3
age (3) 3
algorithms (3) 3
anemia (3) 3
bone marrow blasts (3) 3
cancer stem cells (3) 3
cells (3) 3
chromosomal-abnormalities (3) 3
comorbidity index (3) 3
criteria (3) 3
development and progression (3) 3
elderly (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 04/2016, Volume 9, Issue 1, pp. 39 - 16
Journal Article
Blood, ISSN 0006-4971, 09/2012, Volume 120, Issue 12, pp. 2454 - 2465
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 6/2018, Volume 11, Issue 2, pp. 97 - 100
To review data on acute myeloid leukemia (AML) presented at the 2017 meeting of the American Society of Hematology (ASH) and to discuss these data within the... 
AML | Medicine & Public Health | Maintenance therapy | Targeted therapy | Hypomethylating agents | Oncology | Medicine/Public Health, general | Next generation sequencing | Family medicine | Chemotherapy | Trade and professional associations | Cancer
Journal Article
Memo - Magazine of European Medical Oncology, ISSN 1865-5041, 06/2017, Volume 10, Issue 2, pp. 58 - 61
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s12254-017-0330-8 For... 
Checkpoint inhibitors | Iron chelation | Targeted therapy | Hypomethylating agents | Assessment | Anemia | Myelodysplastic syndromes | Trade and professional associations
Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 02/2017, Volume 18, Issue 2, pp. 415 - 415
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 9/2016, Volume 9, Issue 3, pp. 116 - 119
Despite of the progress achieved in recent years for acute myeloid leukemia (AML) treatment, there is still a need for improvement, both for younger and... 
AML | Medicine & Public Health | Targeted therapy | Hypomethylating agents | Stem cell transplantation | Oncology | Clinical trial design | Medicine/Public Health, general | Tyrosine | Chemotherapy | Transplantation | Stem cells | Cancer
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 2/2016, Volume 9, Issue 1, pp. 2 - 3
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s12254-016-0251-y 
Medicine & Public Health | Oncology | Medicine/Public Health, general | Cancer patients | Care and treatment | Aged
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 9/2015, Volume 8, Issue 3, pp. 162 - 165
Treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), especially in older patients with comorbidities, is still a challenge and awaits... 
Treatment | Medicine & Public Health | Oncology | American Society of Hematology | Medicine/Public Health, general | Acute myeloid leukemia | Myelodysplastic syndromes | Comorbidity | Chemotherapy | Cancer
Journal Article
Journal Article
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 12/2014, Volume 7, Issue 4, pp. 194 - 195
Journal Article